If you're exploring medically supervised weight loss, understanding why Semaglutide is often a recommended starting point can help you make an informed decision in consultation with our medical team
However, its important to note that Semigline is not a magic solution for weight loss
methodology (equal)
Key findings: 12 mg dose: Average weight loss of 24.2% of body weight (approximately 58 lbs for a 240 lb individual) 8 mg dose: Average weight loss of 22.8% 4 mg dose: Average weight loss of 17.0% Placebo: Average weight loss of 2.1% Over 90% of participants receiving the 8 mg or 12 mg dose lost at least 10% of body weight Over 75% of participants at the highest dose lost at least 20% of body weight Significant improvements in waist circumference, blood pressure, and lipid profiles were observed across dose groups Phase 2 Trial in Type 2 Diabetes A separate phase 2 trial evaluated retatrutide in adults with type 2 diabetes and obesity (Rosenstock et al., Lancet , 2023)

Injection technique and site selection: Rotate injection sites with each dose to minimize injection-site reactions Acceptable sites include the abdomen (at least 2 inches from the navel), front of the thighs, and outer upper arms Clean the injection site with an alcohol swab and allow it to dry before injecting Inject at a 90-degree angle for most patients
Langsted A, Nordestgaard BG, Kamstrup PR